Cellectis (CLLS) Operating Expenses (2015 - 2026)

Cellectis' Operating Expenses history runs 12 years deep, the most recent figure standing at -$32.7 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 24.83% year-over-year to -$32.7 million; the TTM figure through Mar 2026 stood at -$119.2 million (down 10165.46% YoY), while the FY2025 annual figure was -$112.7 million, changed N/A from the prior year.
• Operating Expenses was -$32.7 million for Q1 2026 at Cellectis, down from -$29.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $85.9 million in Q4 2023 to a low of -$33.0 million in Q1 2022.
• Historically, Operating Expenses has averaged -$14.7 million across 5 years, with a median of -$27.4 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses surged 473.64% in 2023, then plunged 135.64% in 2025.
• A 5-year view of Operating Expenses shows it stood at -$23.0 million in 2022, then soared by 473.64% to $85.9 million in 2023, then slipped by 3.43% to $82.9 million in 2024, then slumped by 135.64% to -$29.6 million in 2025, then retreated by 10.68% to -$32.7 million in 2026.
• The last three Operating Expenses figures came in at -$32.7 million (Q1 2026), -$29.6 million (Q4 2025), and -$29.1 million (Q3 2025), per Business Quant data.